TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Biotechnology

Pharmaceutical

The Basel office likely supports administrative functions and operations management for regional initiatives.

TOLREMO therapeutics' headquarters in Zürich, Switzerland

This department oversees the strategic direction and decision-making processes of the organization through its board members.

This department oversees strategic initiatives and day-to-day operations to enhance organizational efficiency.

This department manages and oversees clinical trials to ensure their successful execution and compliance with regulatory standards.

This department oversees the organization's operational strategies, ensuring efficient processes and resource management.